MOTS-c vs SS-31: Comparing Two Mitochondrial Peptides

MOTS-c vs SS-31 is a comparison that shows up constantly in mitochondrial research discussion, because both peptides get filed under the same broad label. They are not built the same way and were not studied for the same mechanism. This guide lines up what actually separates MOTS-c and SS-31, and walks through the reconstitution math that applies equally to both. It is written for research and educational purposes only and is not medical advice.

Where MOTS-c and SS-31 come from

MOTS-c is unusual among research peptides because of where its instructions live. It's a short, 16-amino-acid peptide encoded within mitochondrial DNA rather than the cell's nuclear genome, discovered through analysis of that mitochondrial sequence. It has been studied in the context of metabolic regulation — how cells respond to stress and manage energy use, including during exercise. Much of the published work is in cell and animal models, with human data still limited.

SS-31 is built differently. Also known as elamipretide, it's a four-amino-acid synthetic peptide with alternating aromatic and basic residues, engineered to cross into cells and concentrate in mitochondria rather than diffusing through tissue at random. That structure lets it bind cardiolipin, a phospholipid found almost exclusively in the inner mitochondrial membrane. SS-31 has been studied in the context of mitochondrial dysfunction — how cells under metabolic stress in heart, kidney, and skeletal muscle tissue hold up structurally and functionally.

Both peptides target mitochondrial biology. One is a mitochondrially-encoded signaling peptide studied for metabolic regulation; the other is a synthetic, cardiolipin-binding peptide studied for mitochondrial membrane integrity under stress. Same organelle, different mechanism.

Regulatory and research status

Neither peptide carries FDA approval for any use. Both are sold as lyophilized research compounds, not as drugs or supplements, and nothing in either compound's research history describes a use recommendation.

The evidence base differs in maturity. SS-31's human research history, under the elamipretide name, extends further into registered human clinical trial activity than MOTS-c's does — MOTS-c's published work remains weighted more heavily toward cell and animal studies. Neither compound's research history, however established, amounts to FDA approval or a validated clinical dose. Treat both as compounds with an evolving evidence base, not as settled, universally approved products.

Typical vial concentrations

Both peptides commonly arrive as lyophilized powder in a sealed vial, reconstituted with bacteriostatic water before use — the same starting point as any other research peptide on this site:

Peptide	Common vial size	Reference water volume	Concentration
MOTS-c	10 mg	2 mL	5,000 mcg/mL
SS-31	10 mg	2 mL	5,000 mcg/mL

These are reference points, not fixed requirements. The peptide reconstitution calculator recalculates concentration and syringe units for any vial size and water volume entered, for either compound.

Worked example: same formula, different vials

The formula behind every reconstitution on this site doesn't change based on which peptide is in the vial: concentration equals mass in mg divided by water volume in mL, and syringe units equal that solution's volume in mL multiplied by 100 on a U-100 insulin syringe.

MOTS-c. A 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 5 mg ÷ 2 mL = 2.5 mg/mL, which is 2,500 mcg/mL. A 500 mcg research reference amount from that vial works out to 500 mcg ÷ 2,500 mcg/mL = 0.2 mL, and 0.2 mL × 100 units/mL = 20 units on a U-100 syringe.

SS-31. A 10 mg vial reconstituted with 1 mL of bacteriostatic water gives 10 mg ÷ 1 mL = 10 mg/mL, or 10,000 mcg/mL. A 1 mg (1,000 mcg) research reference amount from that vial works out to 1,000 mcg ÷ 10,000 mcg/mL = 0.1 mL, and 0.1 mL × 100 units/mL = 10 units on a U-100 syringe.

Two different vial sizes, two different water volumes, and two different unit counts — the arithmetic is the same three steps every time: find concentration, divide the target amount by concentration to get volume, multiply volume by 100 for units.

Why one calculator covers both

The step most likely to introduce error isn't drawing the syringe — it's the concentration math that happens before it. A U-100 insulin syringe always reads 100 units per mL, so how much peptide each unit represents depends entirely on how much bacteriostatic water went into the vial. That's true whether the vial holds MOTS-c, SS-31, or any other lyophilized research peptide. Get the water volume wrong once, and every draw calculated from it inherits that same error. That's the reasoning behind building a single peptide calculator around the mass-divided-by-water-volume formula rather than a separate tool per compound. For the general mixing walkthrough, see how to calculate a peptide reconstitution ratio.

Where the comparison breaks down

The reconstitution math is identical for MOTS-c and SS-31. Their structure, origin, and research focus are not. MOTS-c is a mitochondrially-encoded peptide studied mainly in metabolic and exercise-stress contexts, with a research base still weighted toward cell and animal models. SS-31 is a synthetic, cardiolipin-binding peptide studied in mitochondrial dysfunction across heart, kidney, and skeletal muscle tissue, with a longer history of registered human clinical trial activity behind the elamipretide name. Grouping them together because both get filed under "mitochondrial peptides" glosses over a real difference in what each one is and how far its research has progressed.

Common mistakes

• Assuming a shared mitochondrial focus means shared mechanism. MOTS-c and SS-31 act through unrelated pathways — one is a signaling peptide, the other binds a specific membrane lipid.
• Treating either compound's research history as equivalent to FDA approval. Neither is FDA-approved, regardless of how much clinical trial activity exists behind it.
• Confusing mg and mcg. Both peptides are commonly referenced in microgram-range research amounts. 1 mg equals 1,000 mcg, and misreading one for the other produces a 1,000x error in the calculation.
• Reusing a concentration from a different vial. A 5,000 mcg/mL result only holds for the exact vial size and water volume it came from. Recalculate rather than assuming the last vial's numbers still apply.
• Shaking instead of swirling. Vigorous shaking can degrade a reconstituted peptide; swirl the vial gently instead.

Related

For the general mixing and storage steps behind every worked example on this page, see how to reconstitute peptides. Or enter a vial size, water volume, and target amount into the free peptide calculator to get exact syringe units for either compound.